Skip to content
Clinical Trials – home

MD Korczowski Bartosz Gabinet Lekarski

Verified siteinfo

Poland ul. Litewska 4A/7, 35-302 Rzeszow, Poland

  • 10 trials recruiting
  • Colitis ulcerative · Crohn's disease · Juvenile psoriatic arthritis
  • Adults and children

About Specializations

MD Korczowski Bartosz Gabinet Lekarski in Rzeszow, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Juvenile psoriatic arthritis, Acute haemorrhagic ulcerative colitis, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

At MD Korczowski Bartosz Gabinet Lekarski in Rzeszow, much of the research focuses on digestive system diseases, especially inflammatory bowel disease such as Crohn’s disease and ulcerative colitis. These studies are designed to assess new and existing therapies, with attention to symptom control, remission, and long-term treatment benefit in pediatric patients.

  • Testing treatments for Crohn’s disease and ulcerative colitis in children and adolescents
  • Evaluating therapies for complex perianal fistulas and other difficult-to-manage bowel complications
  • Comparing treatment effectiveness for improving clinical remission and digestive health outcomes

The site is also involved in work on gastroesophageal reflux disease, erosive esophagitis, and related upper digestive conditions, broadening its pediatric gastroenterology research portfolio.

Immune System Diseases

Research in immune system diseases at this pediatric center includes studies in Crohn’s disease, ulcerative colitis, and juvenile psoriatic arthritis. The main goal is to better understand how immune-targeted treatments can reduce inflammation and support sustained disease control in young patients.

  • Studying immune-modulating therapies for pediatric inflammatory bowel disease
  • Assessing treatment benefit in juvenile psoriatic arthritis
  • Monitoring long-term safety and effectiveness of biologic therapies

These trials reflect a strong focus on immune-mediated conditions, with research aimed at improving everyday disease management and reducing the burden of chronic inflammation.

Nutritional and Metabolic Diseases

The site also supports studies in nutritional and metabolic diseases, including obesity or overweight and iron deficiency anemia. This work explores new ways to improve metabolic health and address common pediatric nutritional problems that can affect growth, energy, and overall well-being.

  • Evaluating approaches for iron deficiency anemia in children
  • Studying treatment strategies related to obesity and weight-related health concerns
  • Looking at supportive care for children at risk of nutritional deficiency

This area complements the gastroenterology focus by addressing conditions that often overlap with chronic digestive illness and pediatric health challenges.

Skin and Connective Tissue Diseases

Clinical research in skin and connective tissue diseases includes juvenile psoriatic arthritis, a condition that affects both the joints and the immune system. The studies aim to evaluate how well targeted treatments can improve symptoms, function, and long-term disease control in children.

  • Investigating therapies for juvenile psoriatic arthritis
  • Assessing disease control in inflammatory conditions affecting the skin and joints
  • Supporting research on pediatric autoimmune disease

This research adds an important rheumatologic dimension to the site’s pediatric clinical trial activity.

Immune System Processes

A further area of interest is immune system processes, where studies are examining how inflammation develops and how it can be controlled more effectively. At this site, that research is closely tied to chronic intestinal and autoimmune diseases in children.

  • Exploring inflammatory pathways involved in pediatric bowel disease
  • Supporting development of treatments that target immune-driven inflammation
  • Evaluating whether therapies can improve remission and reduce disease activity

Overall, the research profile at MD Korczowski Bartosz Gabinet Lekarski centers on helping children with chronic immune-related conditions through studies of treatment effectiveness, safety, and long-term disease management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Litewska 4A/735-302 RzeszowPoland
Recruiting now
10 trials
Conditions studied
11
Partner status
Verified site

More sites in RzeszowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

27 clinical trials

Crohn's disease

Recruiting

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Coeliac disease

Recruiting

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH

Colitis ulcerative+1

Recruiting

Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Vedolizumab
  • Sponsor:Takeda Development Center Americas Inc.

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative+1

Recruiting

Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn's Disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Prednisone
  • Sponsor:Takeda Development Center Americas Inc.

Crohn's disease

Recruiting

Study of Mirikizumab for Children with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Study comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Ferumoxytol
  • Sponsor:Amag Pharmaceuticals Inc.

Colitis ulcerative+2

Recruiting

Study on the Long-term Safety of Guselkumab for Children with Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Colitis ulcerative

Not yet recruiting

Phase 2b Study of ATH-063 in Adults with Biologic‑Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.